Startups
Neomed is a Brazilian Healthtech company with a mission to close the gap between symptoms and treatment. Founded in 2016, Neomed's proprietary platform, Octopus, connects specialist doctors with clinics and hospitals all over Brazil. Highly trained doctors analyze exams and return a medical report within 24 hours, speeding up the diagnostic process, while reducing at least 60% of the costs for clinics and hospitals as well as guaranteeing access to a quality diagnostic for patients.
Recently, Neomed has also expanded into two new business fronts, developing solutions to aid in the monitoring and treatment of chronic (hypertensive) patients, as well as to use AI to identify cardiovascular emergencies and offer urgent treatment for acute patients. Since it started, Neomed has helped over 500.000 patients and is present in more than 150 clinics, hospitals, and laboratories of some of the largest health groups in Brazil.
Recently, Neomed has also expanded into two new business fronts, developing solutions to aid in the monitoring and treatment of chronic (hypertensive) patients, as well as to use AI to identify cardiovascular emergencies and offer urgent treatment for acute patients. Since it started, Neomed has helped over 500.000 patients and is present in more than 150 clinics, hospitals, and laboratories of some of the largest health groups in Brazil.
Overview
Location
Brazil, São Paulo
Employees
11-50
Phone
+55 11 94197-2781
Founded date
2016
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 9, 2018 | Brazil’s healthtech sector is new hot spot | Manoel Lemos Contributor Manoel Lemos is a managing partner of Redpoint eventures, the Brazilian-focused arm of the Silicon Valley venture firm Redpoint. More posts by this contributor Brazil’s tech startups begin to expand globally Silicon... |
| Nov 8, 2012 | NeoMed announces the successful sale of Vessix Vascular to Boston Scientific for up to $425M | NeoMed Management is pleased to announce that Vessix Vascular, Inc., an emerging medical technology company in which NeoMed has been the lead investor since 2007, has agreed to be acquired by Boston Scientific Corp., a leading US headquarte... |
| Startup especializada no processamento de laudos médicos recebe aporte de R$ 6,5 milhões | A Neomed, startup que oferece soluções para simplificar a relação entre clínicas, laboratórios e hospitais que necessitam de laudos médicos, recebeu um aporte de R$ 6,5 milhões. A rodada de investimentos foi liderada pela Positive Ventures,... |
Reviews 0
FAQ about Neomed
When was Neomed founded?
Neomed was founded in 2016.
What has the press written about Neomed?
Parsers VC has collected 4 articles mentioning Neomed, among them “Brazil’s healthtech sector is new hot spot” (Oct 9, 2018) and “NeoMed announces the successful sale of Vessix Vascular to Boston Scientific for up to $425M” (Nov 8, 2012).
Is Neomed still active?
Yes, Neomed is active; its latest activity on Parsers VC dates from Mar 12, 2021.